Stay updated on Pembrolizumab in Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T15:38:04.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces an update about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-24T18:38:18.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T20:34:06.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.0 to v3.7.1. The page still displays a 403 error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-10T20:47:05.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error instead of the detailed content, with a standard header/footer and a navigation bar indicating access is blocked.
    Difference
    21%
    Check dated 2026-09-19T19:26:23.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page displays an updated revision label from v3.6.5 to v3.6.6, representing a small maintenance update to the site's underlying version rather than a content change.
    Difference
    0.1%
    Check dated 2026-08-29T20:22:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page.